BIOFRONTERA INC. ANNOUNCES DATABASE LOCK OF PHASE 3 STUDY OF AMELUZ®-PHOTODYNAMIC THERAPY (PDT) IN THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA (SBCC)

Reuters · 10/14 14:30

Please log in to view news